Table: Rohto - 9-MTH group results

Rohto Pharmaceutical

10/02/2021 06:00

Feb 10 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              129.61              138.12           183.00    
                   (-6.2 pct)          (+2.5 pct)       (-2.8 pct)  
  Operating           17.06               18.13            21.80    
                   (-5.9 pct)          (+5.4 pct)       (-5.6 pct)  
  Recurring           17.43               18.07            22.10    
                   (-3.6 pct)          (+2.6 pct)       (-2.8 pct)  
  Net                 11.08               12.56            14.00    
                   (-11.8 pct)         (+15.6 pct)      (-9.2 pct)  
  EPS               97.16 yen          110.17 yen       122.73 yen  
  EPS Diluted       96.88 yen          109.82 yen                   
  Ann Div                               26.00 yen        27.00 yen  
  -Q2 div           13.00 yen           13.00 yen                   
  -Q4 div                               13.00 yen        14.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T